688166 博瑞医药
已收盘 05-09 15:00:01
资讯
新帖
简况
东吴证券:给予博瑞医药增持评级
证券之星 · 10:28
东吴证券:给予博瑞医药增持评级
博瑞医药05月09日主力净流出545.5万元 散户资金买入
市场透视 · 07:21
博瑞医药05月09日主力净流出545.5万元 散户资金买入
化学制药行业盘中拉升,复旦复华涨5.49%
市场透视 · 01:35
化学制药行业盘中拉升,复旦复华涨5.49%
博瑞医药定向增发点评与公司近况更新:募资5亿 实控人全额认购 管线进展顺利 催化丰富
东吴证券 · 05-08 16:00
博瑞医药定向增发点评与公司近况更新:募资5亿 实控人全额认购 管线进展顺利 催化丰富
博瑞医药:申请注册发行不超过3亿元中期票据
格隆汇资讯 · 05-08 11:27
博瑞医药:申请注册发行不超过3亿元中期票据
5月8日博瑞医药涨6.10%,上银慧恒收益增强债券A基金重仓该股
证券之星 · 05-08 08:27
5月8日博瑞医药涨6.10%,上银慧恒收益增强债券A基金重仓该股
博瑞医药涨5%创近4年新高
智选洞察 · 05-08 01:47
博瑞医药涨5%创近4年新高
博瑞医药05月07日遭主力抛售2408.3万元
市场透视 · 05-07 07:21
博瑞医药05月07日遭主力抛售2408.3万元
博瑞医药04月30日遭主力抛售4177.4万元
市场透视 · 04-30
博瑞医药04月30日遭主力抛售4177.4万元
A股创新药概念股震荡走强,博瑞医药涨超10%,创4年新高,艾迪药业、康辰药业涨超6%,诺思兰德、百利天恒、荣昌生物、君实
美港电讯 · 04-28
A股创新药概念股震荡走强,博瑞医药涨超10%,创4年新高,艾迪药业、康辰药业涨超6%,诺思兰德、百利天恒、荣昌生物、君实
博瑞医药04月25日获主力加仓218万元
市场透视 · 04-25
博瑞医药04月25日获主力加仓218万元
博瑞医药04月24日主力净流入210万元 散户资金抛售
市场透视 · 04-24
博瑞医药04月24日主力净流入210万元 散户资金抛售
AACR即将开幕,医药或迎密集催化
Ofweek维科网 · 04-24
AACR即将开幕,医药或迎密集催化
博瑞医药04月23日主力净流出1050万元 散户资金买入
市场透视 · 04-23
博瑞医药04月23日主力净流出1050万元 散户资金买入
奥司他韦需求下滑,博瑞医药Q1归母净利暴跌79%,押注减肥药能掀起多大波澜?
证券之星 · 04-23
奥司他韦需求下滑,博瑞医药Q1归母净利暴跌79%,押注减肥药能掀起多大波澜?
博瑞医药4月22日现1笔大宗交易 成交金额517.83万元
新浪证券-红岸工作室 · 04-22
博瑞医药4月22日现1笔大宗交易 成交金额517.83万元
化学制药行业盘中拉升,威尔药业涨9.09%
市场透视 · 04-22
化学制药行业盘中拉升,威尔药业涨9.09%
美国关税或致药品短缺?行业警告:低利润仿制药面临停产危机
华尔街见闻 · 04-21
美国关税或致药品短缺?行业警告:低利润仿制药面临停产危机
博瑞医药04月21日主力净流入2156万元 散户资金抛售
市场透视 · 04-21
博瑞医药04月21日主力净流入2156万元 散户资金抛售
博瑞医药涨5% 券商增持
智选洞察 · 04-21
博瑞医药涨5% 券商增持
公司概况
公司名称:
博瑞生物医药(苏州)股份有限公司
所属行业:
医药制造业
上市日期:
2019-11-08
主营业务:
博瑞生物医药(苏州)股份有限公司的主营业务是医药中间体、原料药和制剂产品的研发、生产。公司的主要产品是抗病毒、抗真菌、免疫抑制、呼吸系统、抗肿瘤、恩替卡韦、奥司他韦、卡泊芬净、米卡芬净钠。公司先后获得“国家知识产权示范企业”、“国家知识产权优势企业”、“2017年度中国专利优秀奖”、“第十一届中国药学会科学技术奖一等奖”等多项荣誉。
发行价格:
12.71
{"stockData":{"symbol":"688166","market":"SH","secType":"STK","nameCN":"博瑞医药","latestPrice":50.36,"timestamp":1746774001000,"preClose":51.35,"halted":0,"volume":7401548,"delay":0,"changeRate":-0.0193,"floatShares":422000000,"shares":422000000,"eps":0.3268,"marketStatus":"已收盘","change":-0.99,"latestTime":"05-09 15:00:01","open":51.7,"high":52.33,"low":50.32,"amount":378000000,"amplitude":0.0391,"askPrice":50.37,"askSize":61,"bidPrice":50.36,"bidSize":187,"shortable":0,"etf":0,"ttmEps":0.3268,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":51.35,"symbolType":"stock_kcb","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":56.49,"lowLimit":46.22,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":422469516,"isCdr":false,"pbRate":8.77,"roa":"--","peRate":154.100367,"roe":"0.53%","epsLYR":0.45,"committee":0.259499,"marketValue":21276000000,"turnoverRate":0.0175,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-05-12。","afterMarket":{"amount":0,"volume":0,"close":50.36,"buyVolume":500,"sellVolume":0,"time":1746776038029,"indexStatus":"已收盘 05-09 15:30:00","preClose":51.35},"floatMarketCap":21276000000},"requestUrl":"/m/hq/s/688166/wiki","defaultTab":"wiki","newsList":[{"id":"2534210645","title":"东吴证券:给予博瑞医药增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2534210645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534210645?lang=zh_cn&edition=full","pubTime":"2025-05-09 18:28","pubTimestamp":1746786504,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对博瑞医药进行研究并发布了研究报告《定向增发点评与公司近况更新:募资5亿,实控人全额认购,管线进展顺利,催化丰富》,给予博瑞医药增持评级。此外,3月21日,药物临床试验登记与信息公示平台显示,博瑞医药启动了BGM0504对比替尔泊肽的减重II期临床试验。最新盈利预测明细如下:该股最近90天内共有4家机构给出评级,买入评级3家,增持评级1家;过去90天内机构目标均价为37.21。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900031386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","688166"],"gpt_icon":0},{"id":"2534172317","title":"博瑞医药05月09日主力净流出545.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2534172317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534172317?lang=zh_cn&edition=full","pubTime":"2025-05-09 15:21","pubTimestamp":1746775286,"startTime":"0","endTime":"0","summary":"05月09日, 博瑞医药股价跌1.93%,报收50.36元,成交金额3.8亿元,换手率1.75%,振幅3.91%,量比0.87。博瑞医药今日主力资金净流出545.5万元,上一交易日主力净流入766.1万元。该股近5个交易日上涨2.84%,主力资金累计净流出7598.5万元;近20日主力资金累计净流出1.9亿元,其中净流出天数为12日。|05月09日主力加仓幅度排名||#|股票简称|主力净额占比|#|中国瑞林|10.75%|#|星德胜|9.03%|#|科蓝软件|6.29%|#|...|...|#2293|博瑞医药|-0.03%|博瑞医药所在的化学制药行业,今日主力净流出4.10亿元,行业排名37/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509173936a6d8e408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509173936a6d8e408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688166"],"gpt_icon":0},{"id":"2534914047","title":"化学制药行业盘中拉升,复旦复华涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534914047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534914047?lang=zh_cn&edition=full","pubTime":"2025-05-09 09:35","pubTimestamp":1746754541,"startTime":"0","endTime":"0","summary":"05月09日,化学制药行业盘中拉升,截至09点35分,化学制药行业整体指数上涨0.69%,报11095.540点。从个股上来看,该行业的成分股中,复旦复华涨5.49%,舒泰神涨幅超过5%。从资金上来看,截止发稿,化学制药行业主力净流入为1308.51万,其中复旦复华受到资金热捧,主力净流入1798.12万;拉长时间线来看,该板块近20日主力资金净流入-53.31亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509093541a6d86536&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509093541a6d86536&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0175","603168","688578","BK0185","600420","600624","688566","600513","600216","601089","600380","605507","600812","603707","600200","BK0122","688189","688117","600079","600276","600062","603669","603367","600267","605177","688506","600521","603229","BK0239","BK0075","605116","BK0028","688166","600488","BK0188","BK0010","600613"],"gpt_icon":0},{"id":"2534176381","title":"博瑞医药定向增发点评与公司近况更新:募资5亿 实控人全额认购 管线进展顺利 催化丰富","url":"https://stock-news.laohu8.com/highlight/detail?id=2534176381","media":"东吴证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534176381?lang=zh_cn&edition=full","pubTime":"2025-05-09 00:00","pubTimestamp":1746720000,"startTime":"0","endTime":"0","summary":"此外,3 月21 日,药物临床试验登记与信息公示平台显示,博瑞医药启动了BGM0504 对比替尔泊肽的减重II 期临床试验。公司2024年报显示新增BGM0504 口服剂型管线与BGM1812管线。头对头潜在药王替尔泊肽,彰显公司对BGM0504 信心。目前唯一上市的amylin药物为阿斯利康的普兰林肽,仅获批糖尿病适应症,减重处在2 期临床。目前公司正在开发口服BGM0504 片剂,处在临床前阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509165635a6d8d58a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509165635a6d8d58a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688166","BK0239"],"gpt_icon":0},{"id":"2533855189","title":"博瑞医药:申请注册发行不超过3亿元中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2533855189","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533855189?lang=zh_cn&edition=full","pubTime":"2025-05-08 19:27","pubTimestamp":1746703654,"startTime":"0","endTime":"0","summary":"格隆汇5月8日丨博瑞医药(688166.SH)公布,为拓宽公司融资渠道,降低融资成本,根据《中华人民共和国公司法》《银行间债券市场非金融企业债务融资工具管理办法》等相关规定,结合业务发展需要,博瑞生物医药(苏州)股份有限公司拟向中国银行间市场交易商协会申请注册发行不超过3亿元(含3亿元)的中期票据,并在中期票据注册额度有效期内,根据市场情况以及公司自身资金需求状况在中国境内一次或分期发行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081927449753290f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081927449753290f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688166","BK0239"],"gpt_icon":0},{"id":"2533973427","title":"5月8日博瑞医药涨6.10%,上银慧恒收益增强债券A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533973427","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533973427?lang=zh_cn&edition=full","pubTime":"2025-05-08 16:27","pubTimestamp":1746692873,"startTime":"0","endTime":"0","summary":"证券之星消息,5月8日博瑞医药涨6.10%创60日新高,收盘报51.35元,换手率2.47%,成交量10.42万手,成交额5.32亿元。融资融券方面近5日融资净流入2306.16万,融资余额增加;融券净流入1950.0,融券余额增加。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为上银基金的上银慧恒收益增强债券A。上银慧恒收益增强债券A目前规模为0.85亿元,最新净值0.8643,较上一交易日下跌0.33%,近一年上涨8.28%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050800022672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688166","BK0239"],"gpt_icon":0},{"id":"2533192919","title":"博瑞医药涨5%创近4年新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2533192919","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533192919?lang=zh_cn&edition=full","pubTime":"2025-05-08 09:47","pubTimestamp":1746668845,"startTime":"0","endTime":"0","summary":"05月08日,博瑞医药股价大幅上涨,截至09点47分,博瑞医药上涨5.00%,报50.82元/股,创近4年新高,突破50元整数关口,成交1.49亿元,换手率0.71%。资金动向截止发稿,博瑞医药获得主力净流出634万元,其中超大单流入707万元,大单流出1341万元。主营业务及业绩博瑞医药公司主营业务为研发和生产高端仿制药和原创性新药。最新财报显示,今年一季报,博瑞医药实现营业收入2.49亿元,同比减少26.81%,净利润为1,295.98万元,同比减少79.77%,基本每股收益为0.03元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508094730a476086f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508094730a476086f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688166"],"gpt_icon":0},{"id":"2533152674","title":"博瑞医药05月07日遭主力抛售2408.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533152674","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533152674?lang=zh_cn&edition=full","pubTime":"2025-05-07 15:21","pubTimestamp":1746602462,"startTime":"0","endTime":"0","summary":"05月07日, 博瑞医药股价跌1.41%,报收48.40元,成交金额4.5亿元,换手率2.15%,振幅5.52%,量比0.95。博瑞医药今日主力资金净流出2408.3万元,连续5日净流出,上一交易日主力净流出1233.4万元。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为70.00%,平均跌幅为3.60%。该股近5个交易日上涨10.08%,主力资金累计净流出1.7亿元;近20日主力资金累计净流出3.2亿元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507165721a4751c10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507165721a4751c10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688166","BK0239"],"gpt_icon":0},{"id":"2531835810","title":"博瑞医药04月30日遭主力抛售4177.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531835810","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531835810?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:21","pubTimestamp":1745997693,"startTime":"0","endTime":"0","summary":"04月30日, 博瑞医药股价跌0.82%,报收48.57元,成交金额3.9亿元,换手率1.91%,振幅4.84%,量比0.94。博瑞医药今日主力资金净流出4177.4万元,连续3日净流出,上一交易日主力净流出6172.5万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为68.42%,平均跌幅为3.42%。该股近5个交易日上涨15.73%,主力资金累计净流出1.2亿元;近20日主力资金累计净流出1.7亿元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430165253a6ce93f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430165253a6ce93f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688166"],"gpt_icon":0},{"id":"2530909604","title":"A股创新药概念股震荡走强,博瑞医药涨超10%,创4年新高,艾迪药业、康辰药业涨超6%,诺思兰德、百利天恒、荣昌生物、君实","url":"https://stock-news.laohu8.com/highlight/detail?id=2530909604","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530909604?lang=zh_cn&edition=full","pubTime":"2025-04-28 11:06","pubTimestamp":1745809591,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1161","BK1583","688180","BK1574","01877","BK1515","603590","159992","BK0262","LU1969619763.USD","688331","06978","688166","LU1064130708.USD","BK0239","09995","688488","399300","LU2148510915.USD","159982","LU1064131003.USD","LU2328871848.SGD","688506"],"gpt_icon":0},{"id":"2530909141","title":"博瑞医药04月25日获主力加仓218万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530909141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530909141?lang=zh_cn&edition=full","pubTime":"2025-04-25 15:22","pubTimestamp":1745565738,"startTime":"0","endTime":"0","summary":"04月25日, 博瑞医药股价涨4.39%,报收43.97元,成交金额4.47亿元,换手率2.44%,振幅6.15%,量比1.46。博瑞医药今日主力资金净流入218万元,上一交易日主力净流入210万元。该股近5个交易日上涨14.03%,主力资金累计净流入4564万元;近20日主力资金累计净流入1497万元,其中净流入天数为11日。|04月25日主力加仓幅度排名||#|股票简称|主力净额占比|#|N众捷汽车|25.80%|#|天元智能|12.79%|#|九洲集团|10.34%|#|...|...|#1913|博瑞医药|0.01%|博瑞医药所在的化学制药行业,今日主力净流出11.39亿元,行业排名1/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425163424a46687b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425163424a46687b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688166"],"gpt_icon":0},{"id":"2529608907","title":"博瑞医药04月24日主力净流入210万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529608907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529608907?lang=zh_cn&edition=full","pubTime":"2025-04-24 15:20","pubTimestamp":1745479255,"startTime":"0","endTime":"0","summary":"04月24日, 博瑞医药股价涨0.36%,报收42.12元,成交金额1.64亿元,换手率0.92%,振幅2.41%,量比0.54。博瑞医药今日主力资金净流入210万元,上一交易日主力净流出1050万元。该股近5个交易日上涨7.56%,主力资金累计净流入4163万元;近20日主力资金累计净流入4339万元,其中净流入天数为11日。该股主力净额占比0.01%,A股市场排名1420/5414,高于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424161046a6c642f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424161046a6c642f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688166","BK0239"],"gpt_icon":0},{"id":"2529462576","title":"AACR即将开幕,医药或迎密集催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2529462576","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529462576?lang=zh_cn&edition=full","pubTime":"2025-04-24 11:19","pubTimestamp":1745464762,"startTime":"0","endTime":"0","summary":"AACR将于当地时间4月25日至4月30日在美国费城召开,本次会议将有近100家中国药企亮相,带来超200项新药研究结果。恒瑞医药、科伦博泰、信达生物、百利天恒、再鼎医药、复宏汉霖、乐普生物等有望发布重要ADC数据,涉及诸多靶点,中国ADC技术有望在国际舞台崭露头角。近年来,国内创新药在AACR会议上的影响力持续攀升,ADC之外,双抗及小分子疗法市场关注度也较高,或带来更多消息面的催化,恒生医药ETF已连续5日上涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241119259742f8a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241119259742f8a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0183","BK0187","688566","605116","BK0196","600521","600664","688578","603367","600812","BK0175","600420","603676","688506","688602","600062","688247","BK0239","688076","600789","603351","600380","605507","BK0012","600488","688658","603538","600196","688166","688799","688091","600267","BK0188","600216","BK0060","BK0028","159938","BK0096","601089","603669"],"gpt_icon":0},{"id":"2529526660","title":"博瑞医药04月23日主力净流出1050万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2529526660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529526660?lang=zh_cn&edition=full","pubTime":"2025-04-23 15:20","pubTimestamp":1745392812,"startTime":"0","endTime":"0","summary":"04月23日, 博瑞医药股价跌0.31%,报收41.97元,成交金额2.69亿元,换手率1.50%,振幅2.33%,量比0.91。博瑞医药今日主力资金净流出1050万元,上一交易日主力净流入3029万元。该股近5个交易日上涨8.48%,主力资金累计净流入4409万元;近20日主力资金累计净流入6282万元,其中净流入天数为11日。|04月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|健尔康|8.43%|#|新天地|7.95%|#|利安科技|7.56%|#|...|...|#3392|博瑞医药|-0.06%|博瑞医药所在的化学制药行业,今日主力净流出1.78亿元,行业排名28/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423160108a6c4dc1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423160108a6c4dc1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688166","BK0239"],"gpt_icon":0},{"id":"2529428475","title":"奥司他韦需求下滑,博瑞医药Q1归母净利暴跌79%,押注减肥药能掀起多大波澜?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529428475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529428475?lang=zh_cn&edition=full","pubTime":"2025-04-23 15:00","pubTimestamp":1745391606,"startTime":"0","endTime":"0","summary":"近期,生物制药企业博瑞医药发布了2025年一季报,公司业绩大幅下滑,实现营收2.49亿元,同比下降26.81%;归母净利润为1295.98万元,同比暴跌79.77%,经营活动产生的现金流量净额也同比大幅下降27.93%至1.07亿元。证券之星了解到,奥司他韦被称为抗流感神药,2021年和2022年,博瑞医药的磷酸奥司他韦胶囊和磷酸奥司他韦干混悬剂先后获得生产批文。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025042300020617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688166"],"gpt_icon":0},{"id":"2529232220","title":"博瑞医药4月22日现1笔大宗交易 成交金额517.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529232220","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529232220?lang=zh_cn&edition=full","pubTime":"2025-04-22 17:40","pubTimestamp":1745314800,"startTime":"0","endTime":"0","summary":" 4月22日,博瑞医药(维权)收涨2.33%,收盘价为42.10元,发生1笔大宗交易,合计成交量12.3万股,成交金额517.83万元。 第1笔成交价格为42.10元,成交12.30万股,成交金额517.83万元,溢价率为0.00%,买方营业部为广发证券股份有限公司上海南泉北路证券营业部,卖方营业部为中信证券股份有限公司大连分公司。 进一步统计,近3个月内该股累计发生4笔大宗交易,合计成交金额为4340.87万元。该股近5个交易日累计上涨7.59%,主力资金合计净流入6804.46万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-04-22/doc-inetzvkq7612541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688166","BK0239"],"gpt_icon":0},{"id":"2529588153","title":"化学制药行业盘中拉升,威尔药业涨9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529588153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529588153?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:44","pubTimestamp":1745286262,"startTime":"0","endTime":"0","summary":"04月22日,化学制药行业盘中拉升,截至09点44分,化学制药行业整体指数上涨1.01%,报10985.070点。从个股上来看,该行业的成分股中,威尔药业涨9.09%,富祥药业、东诚药业等4只股涨幅超过5%。从资金上来看,截止发稿,化学制药行业主力净流入为-1.59亿,其中东诚药业受到资金热捧,主力净流入2513.18万;拉长时间线来看,该板块近20日主力资金净流入-68.34亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094422a6c316d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094422a6c316d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0239","688117","600789","BK0028","603538","603351","600196","688513","688578","688356","600613","688076","600521","688166","600267","688505","600276","688566","600488","603707","688189","688799","688690","BK0060","600216","600812","688091","600624","688506","603676","600420","605116","603811","603229","605177","605507","600513","688247","BK0275","600380"],"gpt_icon":0},{"id":"2529809163","title":"美国关税或致药品短缺?行业警告:低利润仿制药面临停产危机","url":"https://stock-news.laohu8.com/highlight/detail?id=2529809163","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529809163?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:06","pubTimestamp":1745230017,"startTime":"0","endTime":"0","summary":"特朗普口中的“关税武器”,瞄准了全球仰赖的仿制药供应链。据央视新闻,美国或对进口药品征收关税。特朗普多次放话,药品可能被纳入征税范围。本周,美国商务部也宣布对药品进口是否构成“国家安全风险”启动调查。要知道,仿制药承担了美国约90%的药品供应,本身利润就极其微薄,加征关税一旦成真,部分药企或直接停产。目前美国大部分仿制药产自印度和东南亚,美国很难自给自足。事实上,美国药品供应紧张早已有苗头。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421180725a6c227a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421180725a6c227a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","600624","688356","603168","600664","688513","603707","600276","688076","688506","688799","BK0239","600521","603351","688578","600812","688166","600789","600267","603811","688566","603538","600774","600079","603229","603207","605116","688758","688321","603669","603676","600613"],"gpt_icon":0},{"id":"2529876493","title":"博瑞医药04月21日主力净流入2156万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529876493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529876493?lang=zh_cn&edition=full","pubTime":"2025-04-21 15:22","pubTimestamp":1745220135,"startTime":"0","endTime":"0","summary":"04月21日, 博瑞医药股价涨6.69%,报收41.14元,成交金额3.67亿元,换手率2.16%,振幅7.81%,量比1.53。博瑞医药今日主力资金净流入2156万元,上一交易日主力净流出183万元。该股近5个交易日上涨6.14%,主力资金累计净流入4195万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入4077万元,其中净流入天数为11日。该股主力净额占比0.12%,A股市场排名925/5412,高于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421164511a6c21039&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421164511a6c21039&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688166"],"gpt_icon":0},{"id":"2529705812","title":"博瑞医药涨5% 券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2529705812","media":"智选洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529705812?lang=zh_cn&edition=full","pubTime":"2025-04-21 10:59","pubTimestamp":1745204350,"startTime":"0","endTime":"0","summary":"04月21日,博瑞医药股价大幅上涨,截至10点59分,博瑞医药上涨5.16%,报40.55元/股,突破40元整数关口,成交2.05亿元,换手率1.23%,振幅5.58%。资金动向截止发稿,博瑞医药获得主力净流入1856万元,其中超大单流入3780万元,大单流出1924万元。最新财报显示,今年一季报,博瑞医药实现营业收入2.49亿元,同比减少26.81%,净利润为1,295.98万元,同比减少79.77%,基本每股收益为0.03元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421110058a460698d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421110058a460698d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688166"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746823969649,"stockEarnings":[{"period":"1week","weight":0.0369},{"period":"1month","weight":0.4206},{"period":"3month","weight":0.6832},{"period":"6month","weight":0.6463},{"period":"1year","weight":0.3949},{"period":"ytd","weight":0.6675}],"compareEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.0116},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0595},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"博瑞生物医药(苏州)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"10644人(较上一季度减少15.55%)","perCapita":"39690股","listingDate":"2019-11-08","address":"江苏省苏州市吴中区工业园区星湖街218号纳米科技园C25栋","registeredCapital":"42246万元","survey":" 博瑞生物医药(苏州)股份有限公司的主营业务是医药中间体、原料药和制剂产品的研发、生产。公司的主要产品是抗病毒、抗真菌、免疫抑制、呼吸系统、抗肿瘤、恩替卡韦、奥司他韦、卡泊芬净、米卡芬净钠。公司先后获得“国家知识产权示范企业”、“国家知识产权优势企业”、“2017年度中国专利优秀奖”、“第十一届中国药学会科学技术奖一等奖”等多项荣誉。","listedPrice":12.71},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博瑞医药(688166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博瑞医药(688166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博瑞医药,688166,博瑞医药股票,博瑞医药股票老虎,博瑞医药股票老虎国际,博瑞医药行情,博瑞医药股票行情,博瑞医药股价,博瑞医药股市,博瑞医药股票价格,博瑞医药股票交易,博瑞医药股票购买,博瑞医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博瑞医药(688166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博瑞医药(688166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}